Clinical trial
Resveratrol and Human Hepatocyte Function in Cancer
NCT02261844 is registered in ClinicalTrials.gov with University of Louisville as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Resveratrol and Human Hepatocyte Function in Cancer
- Lead sponsor
- University of Louisville
- Phase
- Phase 1/2
- Overall status
- Withdrawn
- Start date
- December 31, 2015
- Completion date
- June 30, 2016
- Enrollment
- 0 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
liver cancer